Streamlining the conduct of cancer clinical trials: new standard data collection practices for National Cancer Institute late-phase clinical studies
JNCI: Journal of the National Cancer Institute · 2025
DOI: 10.1093/jnci/djae239 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Sheila A Prindiville und 6 weiteren Autor:innen. Beteiligte Einrichtung: Coordinating Center for Clinical Trials, National Cancer Institute, NIH, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Neoplasms, Clinical Trials as Topic, Data Collection, Research Design. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, Alliance for Clinical Trials in Oncology.
Abstract (Originalsprache)
The increase in the complexity of cancer clinical trials over the past several decades has led to a dramatic growth in trial cost and operational burden. The extent and frequency of data collection, particularly in late-phase trials that enroll many participants, have been major contributors to this problem. The Clinical Trials and Translational Research Advisory Committee of the National Cancer Institute (NCI) recently assessed the effect of these stressors on the NCI National Clinical Trials Network (NCTN) and recommended that data collection in late-phase NCTN trials be limited to data elements essential to address the primary and secondary objectives of the trial. The purpose of this commentary is to describe the rationale for this recommendation, progress toward implementation, and the development of new streamlined standard practices for data collection for late-phase NCTN trials effective January 1, 2025.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Coordinating Center for Clinical Trials, National Cancer Institute, NIH, Bethesda, MD, USA.
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
- Flatiron Health, New York, NY, USA.
- Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA.
- Cancer Therapy Evaluation Program, National Cancer Institute, NIH, Bethesda, MD, USA.
- The IDA Science and Technology Policy Institute, Washington, DC, USA.
ORCID-Profile: Sheila A Prindiville, Neal J Meropol, Andrea Denicoff, Judith A Hautala, James H Doroshow
Förderung
- NCI NIH HHS
- NIH HHS
- Alliance for Clinical Trials in Oncology
- Institute of Defense Analyses
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Prindiville, S. A., Mandrekar, S. J., Meropol, N. J., Denicoff, A., Grad, O., Hautala, J. A., & Doroshow, J. H. (2025). Streamlining the conduct of cancer clinical trials: new standard data collection practices for National Cancer Institute late-phase clinical studies. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae239
Vancouver
Prindiville SA, Mandrekar SJ, Meropol NJ, Denicoff A, Grad O, Hautala JA, et al. Streamlining the conduct of cancer clinical trials: new standard data collection practices for National Cancer Institute late-phase clinical studies. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djae239
BibTeX
@article{Prindiville2025,
author = {Prindiville, Sheila A and Mandrekar, Sumithra J and Meropol, Neal J and Denicoff, Andrea and Grad, Oren and Hautala, Judith A and Doroshow, James H},
title = {Streamlining the conduct of cancer clinical trials: new standard data collection practices for National Cancer Institute late-phase clinical studies},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2025},
doi = {10.1093/jnci/djae239}
}
EUVIMED